publication venue for
- The Esophageal and Gastric Microbiome in Health and Disease. 46:121-141. 2017
- Novel Pharmaceutical Approaches to Reflux Disease. 42:93-117. 2013
- Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome: the More Things Change, the More They Stay the Same. 40:87-103. 2011
- New Pharmacologic Approaches in Gastroesophageal Reflux Disease. 39:393-418. 2010
- Nonsteroidal Antiinflammatory Drug-Related Injury to the Gastrointestinal Tract: Clinical Picture, Pathogenesis, and Prevention. 39:433-464. 2010
- Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders, from Rationale to Reality. 39:721-726. 2010
- Preface. 39:xv-xvi. 2010
- The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Bleeding. 38:199-213. 2009
- Medical Management of Gastroesophageal Reflux Disease. 37:879-899. 2008
- Is Irritable Bowel Syndrome a Low-Grade Inflammatory Bowel Disease?. 34:235-245. 2005
- Control of Pepsinogen Synthesis and Secretion. 19:27-40. 1990
- PEPTIC-ULCER DISEASE - PREFACE. 19:R9-R12. 1990